NeuBase Therapeutics, Inc.·4

May 25, 4:13 PM ET

Rojas-Caro Sandra 4

4 · NeuBase Therapeutics, Inc. · Filed May 25, 2021

Insider Transaction Report

Form 4
Period: 2021-05-24
Rojas-Caro Sandra
Chief Medical Officer
Transactions
  • Award

    Employee stock option (right to buy)

    2021-05-24+280,000280,000 total
    Exercise: $5.01Exp: 2031-05-24Common stock (280,000 underlying)
Footnotes (1)
  • [F1]1/4th of the total shares shall vest on the first anniversary of the effective date of employment, and 1/36th of the remaining shares shall vest on a monthly basis starting on the first anniversary of the effective date of employment; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive.

Documents

1 file
  • 4
    tm2117446-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT